Bin Chen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Bone Metabolism and Diseases
- Cancer-related gene regulation
Papers in
- Surgery 39
- Hip and Femur Fractures 5
- Pancreatic function and diabetes 3
-
- Bone Metabolism and Diseases 8
- Epigenetics and DNA Methylation 5
- Co-authors
- Youjia Xu (4 shared papers)Hui Zhang (2 shared papers)Guangsi Shen (2 shared papers)Bo-Jui Chang (4 shared papers)Shi‐xin Du (5 shared papers)Xuedong Li (4 shared papers)Xiaozhong Zhou (1 shared paper)Haibin Zhou (1 shared paper)
- Journals
- Medicine (5 papers)Aging (3 papers)PLoS ONE (3 papers)Cellular Physiology and Biochemistry (2 papers)Disease Markers (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Bin Chen
120 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 268
- Molecular Biology 793
- Geriatrics and Gerontology 34
- Oncology 248
- Surgery 394
Countries citing papers authored by Bin Chen
This map shows the geographic impact of Bin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Chen more than expected).
Fields of papers citing papers by Bin Chen
This network shows the impact of papers produced by Bin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Chen. The network helps show where Bin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 95 | |
| 2 | 2018 | 93 | |
| 3 | 2014 | 73 | |
| 4 | 2015 | 70 | |
| 5 | 2010 | 69 | |
| 6 | 2018 | 67 | |
| 7 | 2014 | 61 | |
| 8 | 2021 | 54 | |
| 9 | 2020 | 53 | |
| 10 | 2014 | 53 | |
| 11 | 2010 | 45 | |
| 12 | 2019 | 44 | |
| 13 | Autophagic degradation of FOXO3a represses the expression of PUMA to block cell apoptosis in cisplatin-resistant osteosarcoma cells. | 2017 | 44 |
| 14 | 2013 | 44 | |
| 15 | 2021 | 41 | |
| 16 | 2022 | 33 | |
| 17 | 2015 | 31 | |
| 18 | 2014 | 31 | |
| 19 | 2011 | 31 | |
| 20 | 2017 | 31 |
About Bin Chen
Bin Chen is a scholar working on Surgery, Molecular Biology, Oncology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 127 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (8 papers), Epigenetics and DNA Methylation (5 papers), Autophagy in Disease and Therapy (5 papers), Hip and Femur Fractures (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Pancreatic function and diabetes (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). The work is most often cited by research in Cancer Research (268 citations), Molecular Biology (793 citations), Geriatrics and Gerontology (34 citations), Oncology (248 citations) and Surgery (394 citations). Bin Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Youjia Xu, Hui Zhang, Guangsi Shen, Bo-Jui Chang, Shi‐xin Du, Xuedong Li, Xiaozhong Zhou, Haibin Zhou, Zhipeng Liu and Ye Yuan. Their work appears in journals such as Medicine, Aging, PLoS ONE, Cellular Physiology and Biochemistry and Disease Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.